Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Voxtur is the Leading Provider of Digital, SaaS Solutions for Real Estate Transactions in N. America

Before we dive into what makes Voxtur Analytics ( TSX-V: VXTR ; OTCQB: VXTRF) a standout PropTech company (and an undervalued investment opportunity), it’s worth highlighting a few recent developments: –Voxtur has seen revenues increase 300% year-over-year a...
Stockhouse Editorial | September 22, 2021 |

Germany starts war on gold

Germans, like Indians and Chinese, love their gold - although their reasons for buying and keeping bullion are somewhat different. In China and India, gold jewelry is a status symbol - a sign of wealth and success. In Germany, owning gold bars and coins, maybe a 24-karat ...
Richard (Rick) Mills | January 24, 2020 |

BIGG Digital Assets, Bitcoin Group, Chainalysis - why invest now?

BIGG Digital Assets, Bitcoin Group, Chainalysis - why invest now? The blockchain hype was around two years ago and a lot has changed since then. A consolidation phase has cleared the market and what has remained are the companies and teams that have been able to convin...
Mario Hose | February 13, 2020 |

This Royalty Generator Expects to Cash In On Multiple Assets

https://soundcloud.com/proven-and-probable/david-cole https://www.streetwisereports.com/article/2020/01/16/royalty-firm-expects-to-cash-in-on-serbian-asset.html David Cole the CEO of EMX Royalty ( TSX.V: EMX | NYSE: EMX) , sits do...
Maurice Jackson | January 16, 2020 |

Coverage Initiated on Oil Company with 'High Growth Ambitions'

The compelling aspects of this investment opportunity are outlined in a Pareto Securities report. In a Jan. 20 research note, analyst Tom Eric Kristiansen reported that Pareto Securities initiated coverage on PetroNor E&P Ltd. (PNOR:OSE) with a Buy rating ...
Streetwise Reports | January 30, 2020 |

'Data Readouts Approaching in Two Pivotal Trials' for Biopharma Targeting Unmet Needs

The next steps for each of the programs are outlined in a Dawson James Securities report. In an Aug. 14 research note, Dawson James Securities analyst Jason Kolbert reported that Soligenix Inc. (SNGX:NASDAQ) "is now focused on the two pivotal programs, i...
Streetwise Reports | August 22, 2019 |

U.S. Biotech Rolls Out New Brachytherapy Delivery Tool Used for Prostate Cancer

The system, target markets and the marketing campaign for it are discussed in a Dawson James Securities report. In a Sept. 26 research note, Dawson James Securities analyst Jason Kolbert reported that IsoRay Inc. (ISR:NYSE.MKT) launched a new marketing campaign call...
Streetwise Reports | October 1, 2019 |

Analyst Believes Biopharma's Alzheimer's Treatment Could Be Superior to Biogen's

How this company's Alzheimer's therapeutic compares to an advanced-stage competitor is outlined in a Dawson James Securities note. In a Dec. 2 research note, Dawson James Securities analyst Jason Kolbert purported that Anavex Life Sciences Corp.'s (AVXL:NASDAQ) ANAV...
Streetwise Reports | December 11, 2019 |

Biotech Announces Deal with Bayer on Non-Hormonal Contraception

Details of the arrangement and an update on the company's pipeline are provided in a Dawson James report. In a Jan. 13 research note, Dawson James Securities analyst Jason Kolbert reported that Daré Bioscience Inc. (DARE:NASDAQ) partnered with Bayer, the company beh...
Streetwise Reports | January 16, 2020 |

Three COVID-19 Patients Treated with PLX Cells

Two programs, one new and the other ongoing, involving Pluristem Therapeutics' regenerative products are reviewed in a Dawson James report. In a March 30 research note, Dawson James Securities analyst Jason Kolbert reported that three high-risk COVID-19 pati...
Streetwise Reports | April 2, 2020 |
1 2 3 4 5 6 7 8 9 10 ...